Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations
   

EFPIA Newsletter 6 February 2020

 
 
 
   

Beating the Big C – together

 
Can we cure cancer?

One of the great advantages of working in Brussels is that you get a truly European perspective on healthcare. Some days, this is inspiring: you see initiatives that share best practices and raise standards of care for millions of citizens. Other days, the picture is less rosy: comparisons between countries tend to put the spotlight on glaring inequalities for patients. And with a complex web of roles and responsibilities, turning knowledge into action is in not always straightforward.

Our hope and our commitment is that all stakeholders will play an active role in charting the way forward in the fight against ‘the Big C’. Cancer is indeed a big challenge and it is one that we can rise to together. The big “C” can also be a signal for hope: a C for “collaboration”, for “commitment” and for “concerted action”. Read more


 
 
 
   

EFPIA calls upon its members to join forces against coronavirus

 

Joining the fight against coronavirus
04 February 2020

We have issued a call to EFPIA members to identify suitable assets in their libraries that could be utilized in the... Read more

 
 
 
   

Events

 

Science, Technology and Regulations Coming Together for Better Patients’ Health
10 February 2020 (Amsterdam)

The primary objective of the Conference is to ensure that all attendees are brought fully up to date with the current... Read more

POSTPONED - China/EU Pharmaceutical Industry Forum
16 March 2020 (Wavre, Belgium)

** Event postponed until Autumn 2020 ** Read more

DIA Europe 2020
17 March 2020 (Brussels, Belgium)

DIA Europe 2020 heads to Brussels, the capital of Europe Read more

Clinical Trial Regulation Information Day for CEE Countries
31 March 2020 (Warsaw, Poland)

Are Central and Eastern European Union member states ready to implement the new EU Clinical Trial Regulation (536/2014)?... Read more

 
 
 
   

What we are reading

 

Novel coronavirus 2019-nCoV exposes a flaw in the Nagoya Protocol
On 05 February 2020 (STAT)

By Thomas B. Cueni, Director General of International Federation of Pharmaceutical Manufacturers (IFPMA) Read more

PARADIGM: a ‘game changer’ for patient engagement in R&D
On 30 January 2020 (IMI)

When and how should the health research and development community involve patients in their work? IMI’s PARADIGM project... Read more

Novel Coronavirus Information Center
On 27 January 2020 (Elsevier)

Elsevier’s free health and medical research on novel coronavirus (2019-nCoV) Read more